Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: romanoff who wrote (10515)	6/18/2018 8:41:21 AM
From: donpat	Respond to of 12873

I bet Fleming was surprised at how long it took, too. 25 years. And with Merck at that. merck.com OUR COLLABORATIONSIn addition to our own antimicrobial research efforts, Merck also works with scientists across the world. Through its Merck Innovation Network (MINt), the company actively collaborates with leading scientists in the antimicrobial field to investigate novel therapeutic targets, evaluate new pathways for drug targeting and develop novel tools and technologies. Merck has a number of ongoing collaborations with scientists at universities including Harvard, Yale and Princeton. ---- Now, with a little help from Merck and Glaxo perhaps this time line could be shortened. It will be a bloody shame if all this effort goes for naught.